Señales en vivo de CLSD | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 may 2024 @ 16:00):

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space...

Stats
Volumen de hoy	182 482
Volumen promedio	379 738
Capitalización de mercado	99.39M
EPS	$0 ( 2024-05-09 )
Próxima fecha de ganancias	( $-0.140 ) 2024-06-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.42
ATR14	$0.00900 (0.68%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-15	Yerxa Benjamin R	Buy	7 813	Common Stock
2024-04-18	Gibney Anthony S	Buy	93 290	Common Stock
2024-04-17	Gibney Anthony S	Buy	6 710	Common Stock
2024-04-15	Gibney Anthony S	Buy	45 000	Stock Option (right to buy)
2024-04-15	Gibney Anthony S	Buy	0

INSIDER POWER
67.80
Last 97 transactions
Buy: 5 503 181 \| Sell: 2 142 358

Volumen Correlación

Largo: -0.15 (neutral)

Corto: 0.00 (neutral)

Signal:(50.988) Neutral

Clearside Biomedical Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Clearside Biomedical Inc Correlación - Moneda/Commodity

0.30
( neutral )

0.24
( neutral )

0.00
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.36
( neutral )

Clearside Biomedical Inc Finanzas

Annual	2023
Ingresos:	$8.23M
Beneficio Bruto:	$7.80M (94.87 %)
EPS:	$-0.530

FY	2023
Ingresos:	$8.23M
Beneficio Bruto:	$7.80M (94.87 %)
EPS:	$-0.530

FY	2022
Ingresos:	$1.33M
Beneficio Bruto:	$1.12M (84.63 %)
EPS:	$-0.570

FY	2021
Ingresos:	$29.58M
Beneficio Bruto:	$29.58M (100.00 %)
EPS:	$0.00632

Financial Reports:

No articles found.

Clearside Biomedical Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.